Drug Chatter -- Tracking biopharma stock chatter

Profile for Eagle Pharmaceuticals, Inc. (EGRX)

« Back to company index

EGRX Chatter Timeline

Stock Ticker for EGRX

Most Active Tweeters for EGRX

UserTweets
@TheMarketsDaily 7
@registrarjourn 7
@OlympiaReport 6
@dailypoliticaln 6
@ZolmaxNews 6

Recent Tweets for EGRX

IngoDoggy @IngoDoggy
Binance is TEMPORARILY accepting new users! Register link and bonus https://t.co/RdDhUme4JU ? 05/25 04:52 $EGRX… https://t.co/HQDuqIlZeH
May 25th 2018, 4:05am
sep_sal @sep_sal
RT @IncredibleTrade: $EGRX worth watch. https://t.co/6n7xD1Sxq4
May 24th 2018, 10:05pm
IncredibleTrade @IncredibleTrade
$EGRX worth watch. https://t.co/6n7xD1Sxq4
May 24th 2018, 10:05pm
OlympiaReport @OlympiaReport
Eagle Pharmaceuticals $EGRX Receives $68.00 Consensus PT from Brokerages https://t.co/zTeiX7hH4d
May 24th 2018, 12:05pm
ledgerzette @ledgerzette
Eagle Pharmaceuticals $EGRX Receives $68.00 Consensus PT from Brokerages https://t.co/jc80OjlaXx
May 24th 2018, 12:05pm
ZolmaxNews @ZolmaxNews
Weekly Investment Analysts’ Ratings Updates for Eagle Pharmaceuticals $EGRX https://t.co/NMMbkvqahk
May 23rd 2018, 8:05pm
ledgerzette @ledgerzette
Weekly Investment Analysts’ Ratings Updates for Eagle Pharmaceuticals $EGRX https://t.co/Vgdw4PlZwv
May 23rd 2018, 8:05pm
dailypoliticaln @dailypoliticaln
Weekly Investment Analysts’ Ratings Updates for Eagle Pharmaceuticals $EGRX https://t.co/xXJOWcFwdt
May 23rd 2018, 8:05pm
OlympiaReport @OlympiaReport
Eagle Pharmaceuticals $EGRX Expected to Post Quarterly Sales of $51.50 Million https://t.co/sv1GcX1k8d
May 23rd 2018, 7:05pm
WeekHerald @WeekHerald
Analysts Anticipate Eagle Pharmaceuticals $EGRX Will Post Earnings of $0.96 Per Share https://t.co/qSK4qTCuz4
May 23rd 2018, 7:05pm
registrarjourn @registrarjourn
Eagle Pharmaceuticals $EGRX Expected to Post Quarterly Sales of $51.50 Million https://t.co/G5mNCsTlX8
May 23rd 2018, 7:05pm
ThisLincolnian @ThisLincolnian
Eagle Pharmaceuticals $EGRX Rating Increased to Strong-Buy at BidaskClub https://t.co/qPTBALRCCI
May 23rd 2018, 6:05am
TranscriptDaily @TranscriptDaily
Eagle Pharmaceuticals $EGRX Rating Increased to Strong-Buy at BidaskClub https://t.co/by5tpwCuxo
May 23rd 2018, 1:05am
ZolmaxNews @ZolmaxNews
Eagle Pharmaceuticals $EGRX Rating Increased to Strong-Buy at BidaskClub https://t.co/dF5J2Z0zUl
May 23rd 2018, 1:05am
TheMarketsDaily @TheMarketsDaily
Eagle Pharmaceuticals $EGRX Expected to Post Quarterly Sales of $51.50 Million https://t.co/jzFPiKnGfV
May 21st 2018, 10:05am
WeekHerald @WeekHerald
Eagle Pharmaceuticals $EGRX Expected to Post Quarterly Sales of $51.50 Million https://t.co/niVBKztqcS
May 21st 2018, 10:05am
dakotafinancial @dakotafinancial
Eagle Pharmaceuticals $EGRX Expected to Post Earnings of $0.96 Per Share https://t.co/B5PzH6Er8s
May 21st 2018, 10:05am
dailypoliticaln @dailypoliticaln
Analysts Anticipate Eagle Pharmaceuticals $EGRX Will Announce Earnings of $0.96 Per Share https://t.co/KKyUflY0xl
May 21st 2018, 10:05am
AmericanBanking @AmericanBanking
Eagle Pharmaceuticals $EGRX Receives Consensus Rating of “Hold” from Analysts https://t.co/JLRB9WCwDX #stocks
May 21st 2018, 9:05am
dakotafinancial @dakotafinancial
Eagle Pharmaceuticals $EGRX Receives Consensus Rating of “Hold” from Analysts https://t.co/kepkwafeLj
May 21st 2018, 9:05am
TheMarketsDaily @TheMarketsDaily
Eagle Pharmaceuticals $EGRX Receives Consensus Rating of “Hold” from Brokerages https://t.co/EI7wXBphQz
May 21st 2018, 9:05am
registrarjourn @registrarjourn
Eagle Pharmaceuticals $EGRX Receives Consensus Rating of “Hold” from Analysts https://t.co/34AEWtKhTz
May 21st 2018, 9:05am
ThisLincolnian @ThisLincolnian
Eagle Pharmaceuticals $EGRX Receives Underperform Rating from Mizuho https://t.co/jlFkURzlqN
May 21st 2018, 7:05am
TranscriptDaily @TranscriptDaily
Eagle Pharmaceuticals $EGRX Receives Underperform Rating from Mizuho https://t.co/0KIZujn2kN
May 21st 2018, 4:05am
TickerReport @TickerReport
Eagle Pharmaceuticals $EGRX Receives Underperform Rating from Mizuho https://t.co/UUrZDEGzyR
May 21st 2018, 4:05am
OlympiaReport @OlympiaReport
Eagle Pharmaceuticals $EGRX Stock Rating Upgraded by BidaskClub https://t.co/xodZZKuO7X
May 21st 2018, 2:05am
dispatchtribune @dispatchtribune
Mizuho Reaffirms Underperform Rating for Eagle Pharmaceuticals $EGRX https://t.co/5KuLX8mfhv
May 20th 2018, 12:05pm
OlympiaReport @OlympiaReport
Eagle Pharmaceuticals $EGRX Stock Rating Reaffirmed by Mizuho https://t.co/TNN1wIYOKd
May 20th 2018, 12:05pm
TheMarketsDaily @TheMarketsDaily
Eagle Pharmaceuticals $EGRX Upgraded by BidaskClub to Strong-Buy https://t.co/M7B7OS82n8
May 20th 2018, 9:05am
registrarjourn @registrarjourn
Eagle Pharmaceuticals $EGRX Upgraded by BidaskClub to Strong-Buy https://t.co/WxxthgXMVs
May 20th 2018, 9:05am
AmericanBanking @AmericanBanking
Eagle Pharmaceuticals $EGRX Rating Increased to Strong-Buy at BidaskClub https://t.co/tW4F2lp64X #stocks
May 19th 2018, 1:05pm
registrarjourn @registrarjourn
Eagle Pharmaceuticals $EGRX Stock Rating Reaffirmed by Mizuho https://t.co/g0ZOWsEBjj
May 19th 2018, 9:05am
registrarjourn @registrarjourn
Brokerages Anticipate Eagle Pharmaceuticals $EGRX to Announce $0.96 EPS https://t.co/Rnjem2dbX9
May 19th 2018, 6:05am
WeekHerald @WeekHerald
Eagle Pharmaceuticals $EGRX Upgraded by BidaskClub to “Strong-Buy” https://t.co/I39PfAydWL
May 19th 2018, 6:05am
ZolmaxNews @ZolmaxNews
Brokerages Anticipate Eagle Pharmaceuticals $EGRX to Announce $0.96 EPS https://t.co/pExRtN4RvH
May 19th 2018, 5:05am
dailypoliticaln @dailypoliticaln
Eagle Pharmaceuticals $EGRX Upgraded by BidaskClub to “Strong-Buy” https://t.co/MLyGd0q8SB
May 19th 2018, 4:05am
TickerReport @TickerReport
Eagle Pharmaceuticals $EGRX Upgraded by BidaskClub to “Strong-Buy” https://t.co/uxEHyBZGrl
May 19th 2018, 4:05am
dakotafinancial @dakotafinancial
Eagle Pharmaceuticals $EGRX Given “Underperform” Rating at Mizuho https://t.co/cXkNu6x6t2
May 18th 2018, 2:05pm
TheMarketsDaily @TheMarketsDaily
Eagle Pharmaceuticals $EGRX Earns “Underperform” Rating from Mizuho https://t.co/kyEelVUiid
May 18th 2018, 2:05pm
ledgerzette @ledgerzette
Eagle Pharmaceuticals $EGRX Given “Underperform” Rating at Mizuho https://t.co/02LrS7SLv9
May 18th 2018, 2:05pm
tymorapro @tymorapro
$EGRX: Exc 6MoHIGH=68.79, hits:1, Rng:27%, ch:+0.5%, AtPivPt, tf:1111110, lowFlt:11M, HiPctSht[33%:11d], DyVol:3T:0… https://t.co/kyTQ8hRP0h
May 18th 2018, 9:05am
ConsumerFeed @ConsumerFeed
$51.50 Million in Sales Expected for Eagle Pharmaceuticals $EGRX This Quarter https://t.co/Jp0s23hnI4
May 18th 2018, 1:05am
AmericanBanking @AmericanBanking
$51.50 Million in Sales Expected for Eagle Pharmaceuticals $EGRX This Quarter https://t.co/CvMX3Gy4QQ #stocks
May 18th 2018, 1:05am
AmericanBanking @AmericanBanking
Eagle Pharmaceuticals’ $EGRX Underperform Rating Reaffirmed at Mizuho https://t.co/l6DW0Riyzc #stocks
May 17th 2018, 3:05pm
tymorapro @tymorapro
$EGRX: At 6MoHIGH=68.79, hits:1, Rng:27%, ch:+1.6%, 0phNearHi, AtgPivH4, 2:4Accel+Dy, allTFs+, lowFlt:11M, HiPctSht[33%:11d]
May 17th 2018, 12:05pm
dailypoliticaln @dailypoliticaln
Mizuho Reiterates “Underperform” Rating for Eagle Pharmaceuticals $EGRX https://t.co/gO8qV6u2Ka
May 17th 2018, 8:05am
ZolmaxNews @ZolmaxNews
Mizuho Reiterates “Underperform” Rating for Eagle Pharmaceuticals $EGRX https://t.co/GJ37KlT3sG
May 17th 2018, 8:05am
AmericanBanking @AmericanBanking
Eagle Pharmaceuticals $EGRX Expected to Announce Earnings of $0.96 Per Share https://t.co/Y5SgCsKms9 #stocks
May 16th 2018, 11:05pm
ThisLincolnian @ThisLincolnian
Eagle Pharmaceuticals $EGRX Expected to Announce Earnings of $0.96 Per Share https://t.co/wlPFGK5Ldc
May 16th 2018, 11:05pm
OlympiaReport @OlympiaReport
Analysts Anticipate Eagle Pharmaceuticals $EGRX to Announce $0.96 EPS https://t.co/B7C1z8aswc
May 16th 2018, 11:05pm

Contact © thinkBiotech LLC 2004 - 2018. All rights reserved.